Chengdu Olymvax Biopharmaceuticals' high P/S ratio may not b...

Chengdu Olymvax Biopharmaceuticals' high P/S ratio may not be justified due to less than stellar revenue forecasts. Unless conditions improve, these prices may not be reasonable. Also, there are 3 warning signs to consider.